Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

LyncMed

Explore full profile

Business-to-business medical device trading platform based in Beijing

Dongcheng District, ChinaFounded 2015Health Tech & Medtech
Valuation $100–250M Last recorded · 2019
Total funding $10–50M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for LyncMed and the history behind them.

About LyncMed

LyncMed, officially known as Lyncmed Medical Technology (Beijing) Co., Ltd., was established in 2015 and is headquartered in Beijing, China. The company was founded by Wang Peng, who serves as the CEO. His background in logistics, supply chain, and a six-year tenure in the global procurement department at Hospira (now part of Pfizer) in Chicago provided him with the foundational expertise to address inefficiencies in the medical supply industry. LyncMed has achieved several funding milestones, including a Series B+ round of $20 million in May 2019. Investors in the company include InnoVen Capital, 5Y Capital, Chunxiao Capital, and Intco Medical, among others.

The firm operates as a comprehensive B2B platform for medical devices and consumables, functioning as both a manufacturer and a trading company. Its business model is centered on streamlining the procurement process for healthcare providers by offering a "one-stop shopping" experience, thereby aiming to lower healthcare costs. LyncMed directly connects with manufacturers, many of whom are CE and FDA certified, to bypass lengthy traditional supply chains that involve multiple intermediaries. The company serves a diverse client base that includes hospitals, clinics, nursing homes, private medical practices, and dental clinics across the globe. To support its international operations, LyncMed has established overseas warehouses and branch companies in locations such as the USA, Italy, Spain, Germany, and Mexico.

LyncMed's product portfolio is extensive, encompassing a wide array of medical disposables and consumables. The company sells products developed in-house as well as those from other leading medical brands. Key product categories include disposable items like gloves, face masks, gowns, and caps, in addition to products for wound care, incontinence, dental procedures, and surgical supplies. The platform gives customers online access to purchase these items, with LyncMed managing quality control, cross-border shipping, and customer service to ensure an efficient and cost-effective procurement experience.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2015
Headquarters
Dongcheng District, China
Open positions
None listed
Dealroom signal
22.0/100
Industry
Health
Sub-industry
Medical Devices
Sector
Health Tech & Medtech, Trading, Wholesale, Supply Chain Management, Pharmacy, Medical Data, Hospital Logistics, Hard Tech
Business model
Manufacturing
Client focus
b2b
Links
Website

Funding history

7 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES B✓Equity / VC May 2019 $20M $80M Undisclosed —
EARLY VCEquity / VC Jan 2019 $0 — InnoVen Capital —
Showing the latest 2 of 7 recorded eventsBook a demo for the full funding history →

Growth signals

LyncMed website traffic

Latest recorded traffic for LyncMed is 160 monthly website visits, down 87.7% over the last three months.

Latest monthly visits160 3-month web change-87.7%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

6 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed1 investor entered at this stage

Series A5 investors entered at this stage

  • Yunqi Partners
  • Chunxiao Capital
  • 5Y Capital
  • INTCO Medical
  • InnoVen Capital
Team profiled 1 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 1 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
🇨🇳 China · Dongcheng District HQ
Book a demo for the full country breakdown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about LyncMed on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See LyncMed’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.